Agnes Koong

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim et al. · The Lancet Diabetes & Endocrinology · 2020 · 93 citations · Full text

Medicine, Cardiology, Pharmacology +12

Interaction between Antibiotic Resistance, Resistance Genes, and Treatment Response for Urinary Tract Infections in Primary Care

Hanley J. Ho, Mei Xuan Tan, Mark Chen et al. · Journal of Clinical Microbiology · 2019 · 66 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore—A cluster randomized controlled trial

Tazeen H. Jafar, Ngiap Chuan Tan, Rupesh M. Shirore et al. · PLoS Medicine · 2022 · 31 citations · Full text

Medicine, Family Medicine, Pharmacotherapy +17

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim et al. · Cardiovascular Diabetology · 2021 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17